This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 104/1/69    most recent CIRCRESAHA.108.188409v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alexis, J. D. Articles by Abe, J.-i. Search for Related Content PubMed PubMed Citation Articles by Alexis, J. D. Articles by Abe, J.-i. Related Collections Cell signalling/signal transduction Smooth muscle proliferation and differentiation Related Article

(Circulation Research. 2009;104:69.)
© 2009 American Heart Association, Inc.

Molecular Medicine

Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor Transcriptional Activity in Vascular Smooth Muscle Cells

Jeffrey D. Alexis, Nadan Wang, Wenyi Che, Nicole Lerner-Marmarosh, Abha Sahni, Vyacheslav A. Korshunov, Yiping Zou, Bo Ding, Chen Yan, Bradford C. Berk, Jun-ichi Abe

From the Aab Cardiovascular Research Institute (J.D.A., N.W., A.S., V.A.K., C.Y., B.C.B., J.-i.A.), Department of Medicine; and Department of Biochemistry (N.L.-M., B.D.), University of Rochester School of Medicine and Dentistry, NY; Carestream Health Inc (W.C.), Rochester, NY; and Department of Surgery (Y.Z.), Beijing PLA 309 Hospital, China.

Correspondence to Jeffrey Alexis, MD, Aab Cardiovascular Research Institute, University of Rochester School of Medicine & Dentistry, 601 Elmwood Ave, Box CVRI, Rochester, NY 14642. E-mail jeffrey_alexis{at}urmc.rochester.edu

Bcr is a serine/threonine kinase activated by platelet-derived growth factor that is highly expressed in the neointima after vascular injury. Here, we demonstrate that Bcr is an important mediator of angiotensin (Ang) II and platelet-derived growth factor–mediated inflammatory responses in vascular smooth muscle cells (VSMCs). Among transcription factors that might regulate Ang II–mediated inflammatory responses we found that ligand-mediated peroxisome proliferator-activated receptor (PPAR) transcriptional activity was significantly decreased by Ang II. Ang II increased Bcr expression and kinase activity. Overexpression of Bcr significantly inhibited PPAR activity. In contrast, knockdown of Bcr using Bcr small interfering RNA and a dominant-negative form of Bcr (DN-Bcr) reversed Ang II–mediated inhibition of PPAR activity significantly, suggesting the critical role of Bcr in Ang II–mediated inhibition of PPAR activity. Point-mutation and in vitro kinase analyses showed that PPAR was phosphorylated by Bcr at serine 82. Overexpression of wild-type Bcr kinase did not inhibit ligand-mediated PPAR1 S82A mutant transcriptional activity, indicating that Bcr regulates PPAR activity via S82 phosphorylation. DN-Bcr and Bcr small interfering RNA inhibited Ang II–mediated nuclear factor B activation in VSMCs. DN-PPAR reversed DN-Bcr–mediated inhibition of nuclear factor B activation, suggesting that PPAR is downstream from Bcr. Intimal proliferation in low-flow carotid arteries was decreased in Bcr knockout mice compared with wild-type mice, suggesting the critical role of Bcr kinase in VSMC proliferation in vivo, at least in part, via regulating PPAR/nuclear factor B transcriptional activity.

Key Words: signal transduction • smooth muscle cell • inflammation

Related Article:

Suppression of Peroxisome Proliferator-Activated Receptor- Activity by Angiotensin II in Vascular Smooth Muscle Involves Bcr Kinase: The Fire That Drowns The Water

Ernesto L. Schiffrin and Pierre Paradis
Circ. Res. 2009 104: 4-6. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				E. L. Schiffrin and P. Paradis Suppression of Peroxisome Proliferator-Activated Receptor-{gamma} Activity by Angiotensin II in Vascular Smooth Muscle Involves Bcr Kinase: The Fire That Drowns The Water Circ. Res., January 2, 2009; 104(1): 4 - 6. [Full Text] [PDF]